Clinical parameters linked with malignancy in endometrial polyps

References

• Dreisler E, Stampe Sorensen S, Ibsen P H, Lose G. Prevalence of endometrial polyps and abnormal uterine bleeding in a Danish population aged 20–74 years. Ultrasound Obstet Gynecol 2009; 33: 102–108
   PubMed Web of Science ®Google Scholar
• Clevenger-Hoeft M, Syrop C H, Stovall D W, Van Voorhis B J. Sonohysterography in premenopausal women with and without abnormal bleeding. Obstet Gynecol 1999; 94: 516–520
   PubMed Web of Science ®Google Scholar
• Sherman M E, Mazur M T, Kurman R J. Benign diseases of the endometrium. Blaustein's Pathology of the Female Genital Tract, R J Kurman. Springer-Verlag, New York 2002; 421–426
   Google Scholar
• Dahjanov, I, Linder, J. Anderson's Pathology10th edn. St. Louis, Mosby–Year Book. 1996; 2231–2309
   Google Scholar
• Anderson M C, Robboy S J, Russel P, Morse A. Endometritis, metaplasias and polyps. Pathology of the Female Reproductive Tract, S J Robboy, M C Anderson, P Russel. Churchill Livingstone, London 2002; 285–303
   Google Scholar
• Bakour S, Khan K S, Gupta J K. The risk of premalignant and malignant pathology in endometrial polyps. Acta Obstet Gynecol Scand 2000; 79: 317–320
   PubMed Web of Science ®Google Scholar
• Savelli L, de Iaco P, Santini D, et al. Histopathologic features and risk factors for benignity, hyperplasia, and cancer in endometrial polyps. Am J Obstet Gynecol 2003; 188: 927–931
   PubMed Web of Science ®Google Scholar
• Goldstein S R, Monteagudo A, Popiolek D, Mayberry P, Timor-Tritsch I. Evaluation of endometrial polyps. Am J Obstet Gynecol 2002; 186: 669–674
   PubMed Web of Science ®Google Scholar
• Anastasiadis P G, Koutlaki N G, Skaphida P G, Galazios G C, Tsikouras P N, Liberis V A. Endometrial polyps: prevalence, detection, and malignant potential in women with abnormal uterine bleeding. Eur J Gynaecol Oncol 2000; 21: 180–183
   PubMed Web of Science ®Google Scholar
• Oguz S, Sargin A, Kelekci S, Aytan H, Tapisiz O L, Mollamahmutoglu L. The role of hormone replacement therapy in endometrial polyp formation. Maturitas 2005; 50: 231–236
   PubMed Web of Science ®Google Scholar
• Anama-Mbatsogo B, le Bouëdec G, Michy T, Bourdel N, Fouilloux G, Dauplat J. Endometrial cancers arising in polyps associated with tamoxifen use. Gynecol Obstet Fertil 2005; 33: 975–979
   PubMedGoogle Scholar
• Farrell R, Scurry J, Otton G, Hacker N F. Clinicopathologic review of malignant polyps in stage 1A carcinoma of the endometrium. Gynecol Oncol 2005; 98: 254–262
   PubMed Web of Science ®Google Scholar
• Hilleeto D, Fadare O, Martel M, Zheng W. Age dependent association of endometrial polyps with increased risk of cancer involvement. World J Surg Oncol 2005; 3: 8
   PubMedGoogle Scholar
• Bettocchi S, Cesi O, Di Venere R, et al. Advanced operative office hysteroscopy without anesthesia: analysis of 501 cases treated with a 5 Fr bipolar electrode. Hum Reprod 2002; 17: 2435–2438
   PubMed Web of Science ®Google Scholar
• Peterson W F, Novak E R. Endometrial polyps. Obstet Gynecol 1956; 8: 40–49
   PubMed Web of Science ®Google Scholar
• Ben-Arie A, Goldchmit C, Laviv Y, et al. The malignant potential of endometrial polyps. Eur J Obstet Gynecol Reprod Biol 2004; 115: 206–210
   PubMed Web of Science ®Google Scholar
• Fernández-Parra J, Rodríguez Oliver A, López Criado S, Parrilla Fernández F, Montoya Ventoso F. Hysteroscopic evaluation of endometrial polyps. Int J Gynaecol Obstet 2006; 95: 144–148
   PubMed Web of Science ®Google Scholar
• Silva E G, Jenkins R. Serous carcinoma in endometrial polyps. Mod Pathol 1990; 3: 120–128
   PubMed Web of Science ®Google Scholar
• Martinez M A, Jou P, Novell R, Cardona M, Alonso I, Vanrell J A. Polipos endometriales: riesgo de malignizacion y correlation clinico-anatomica. Prog Obstet Ginecol 2004; 47: 506–510
   Google Scholar
• Shushan A, Revel A, Rojansky N. How often are endometrial polyps malignant. Gynecol Obstet Invest 2004; 58: 212–215
   PubMed Web of Science ®Google Scholar
• Nappi L, Indraccolo U, Sardo A D, et al. Are diabetes, hypertension, and obesity independent risk factors for endometrial polyps. J Minim Invasive Gynecol 2009; 16: 157–162
   PubMed Web of Science ®Google Scholar
• Cohen I, Bernheim J, Azaria R, Tepper R, Sharony R, Beyth Y. Malignant endometrial polyps in postmenopausal breast cancer tamoxifen-treated patients. Gynecol Oncol 1999; 75: 136–141
   PubMed Web of Science ®Google Scholar
• Antunes A, Jr, Costa-Pavia L, Arthuso M, Costa J V, Pinto-Neto A M. Endometrial polyps in pre- and postmenopausal women: factors associated with malignancy. Maturitas 2007; 57: 415–421
   PubMed Web of Science ®Google Scholar
• Berleire M, Charles A, Galant C, Donnez J. Uterine side effects of tamoxifen: a need for systemic pretreatment screening. Obstet Gynecol 1998; 91: 40–44
   PubMed Web of Science ®Google Scholar
• Deligdisch L, Kalir N, Cohen C J, de Latour M, Le Bouedec G, Penault-Llorca F. Endometrial histopathology in 700 patients treated with tamoxifen for breast cancer. Gynecol Oncol 2000; 78: 181–186
   PubMed Web of Science ®Google Scholar
• Schlesinger C, Kamoi S, Ascher S M, Kendell M, Lage J M, Silverberg S G. Endometrial polyps: a comparison study of patients receiving tamoxifen with two control groups. Int J Gynecol Pathol 1998; 17: 302–311
   PubMed Web of Science ®Google Scholar
• Clark T J, Khan K S, Gupta J K. Current practice for the treatment of benign intrauterine polyps: a national questionnaire survey of consultant gynaecologists in UK. Eur J Obstet Gynecol Reprod Biol 2002; 103: 65–67
   PubMed Web of Science ®Google Scholar